Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Q Shih

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient miceD Q Shih, M A Navas, S Kuwajima, et al.
European Journal of Microbiology & Immunology|February 21, 2012
CD161 DEFINES EFFECTOR T CELLS THAT EXPRESS LIGHT AND RESPOND TO TL1A-DR3 SIGNALINGO Cohavy, D Q Shih, T M Doherty, et al.
Diabetes|July 25, 2000
Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levelsD Q Shih, H M Dansky, M Fleisher, et al.
Nature Genetics|March 30, 2002
beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell massR N Kulkarni, M Holzenberger, D Q Shih, et al.
Diabetes|October 27, 2001
Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolismD Q Shih, S Screenan, K N Munoz, et al.
Alimentary Pharmacology & Therapeutics|July 13, 2012
Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolismD Q Shih, M Nguyen, L Zheng, et al.
Mucosal Immunology|May 23, 2014
Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosisD Q Shih, L Zheng, X Zhang, et al.
Nature Genetics|March 30, 2001
Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolismD Q Shih, M Bussen, E Sehayek, et al.
International Journal of Obesity (2005)|May 11, 2016
Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptorD Hoang-Yen Tran, D Hoang-Ngoc Tran, S A Mattai, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient miceD Q Shih, M A Navas, S Kuwajima, et al.
European Journal of Microbiology & Immunology|February 21, 2012
CD161 DEFINES EFFECTOR T CELLS THAT EXPRESS LIGHT AND RESPOND TO TL1A-DR3 SIGNALINGO Cohavy, D Q Shih, T M Doherty, et al.
Diabetes|July 25, 2000
Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levelsD Q Shih, H M Dansky, M Fleisher, et al.
Nature Genetics|March 30, 2002
beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell massR N Kulkarni, M Holzenberger, D Q Shih, et al.
Diabetes|October 27, 2001
Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolismD Q Shih, S Screenan, K N Munoz, et al.
Alimentary Pharmacology & Therapeutics|July 13, 2012
Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolismD Q Shih, M Nguyen, L Zheng, et al.
Mucosal Immunology|May 23, 2014
Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosisD Q Shih, L Zheng, X Zhang, et al.
Nature Genetics|March 30, 2001
Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolismD Q Shih, M Bussen, E Sehayek, et al.
International Journal of Obesity (2005)|May 11, 2016
Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptorD Hoang-Yen Tran, D Hoang-Ngoc Tran, S A Mattai, et al.
Pageof 1